A series of functional studies were performed to assess the potential
role of the ras-related transformation suppressor gene, Krev-1, in sup
pressing prostate cancer cell growth. Three human prostate cancer cell
lines, PC-3, TSU-Pr1, and DU-145 were transfected with a plasmid cont
aining the Kuev-1 cDNA and a neomycin resistance gene. Selected G418-r
esistant clones were isolated and expanded into cell lines. All cloned
transfectants exhibited a significant reduction in their in vitro gro
wth rates, i.e., longer doubling times, when compared to the parental
cell lines. Molecular analysis of the Kuev-1 cloned transfectants reve
aled that they all contained variable copy numbers of the Krev-1 gene
and expressed high levels of Krev-1 mRNA transcript, as shown by South
ern and Northern analysis, respectively. To determine whether the biol
ogical properties associated with tumorigenicity were changed in these
Krev-1 transfectants, their growth characteristics were examined on t
he basis of their ability to a) form colonies in soft agar, and b) pro
duce tumors in SCID mice. The majority of the Krev-1 transfectants fro
m the PC-3 and TSU-Prl cell lines showed a substantially reduced abili
ty to form colonies in soft agar and produced significantly smaller tu
mors when inoculated into SCID mice. In contrast, there was no signifi
cant reduction in the soft agar colony-forming ability or in vivo tumo
rigenicity of the DU-145 Krev-1 transfectants. These results suggest t
hat the Krev-1 suppressor gene induces partial suppression of the mali
gnant phenotype of human prostate cancer cells containing activated ra
s oncogenes. (C) 1994 Wiley-Liss, Inc.